Be a Smart Investor

Friday, July 29, 2022

AbbVie Confirms FY22 Adj. EPS Outlook - Update

While reporting financial results for the second quarter on Friday, biopharmaceutical company AbbVie Inc. (ABBV) confirmed its adjusted earnings guidance for the full-year 2022.

from RTT - Earnings https://ift.tt/kw3Zj4X
via IFTTT

W.P. Carey Boosts FY22 AFFO Outlook - Update

While reporting its financial results for the second quarter on Friday, net lease real estate investment trust W.P. Carey Inc. (WPC) now projects adjusted funds from operations or AFFO guidance for the full-year 2022 in a range of $5.22 to $5.30 per share, including Real Estate AFFO of between $5.13 and $5.21 per share.

from RTT - Earnings https://ift.tt/YKBs9zb
via IFTTT

P&G Q4 Profit Up 5%, But Misses View; Provides Weak Outlook

Consumer goods giant Procter & Gamble reported on Friday that profit for the fourth quarter increased five percent from last year, driven by net sales growth and lower expenses. Earnings per share for the quarter missed analysts' estimates, but quarterly sales topped expectations by a whisker. Looking ahead, the company initiated earnings and sales growth guidance for full-year 2023 below expectations.

from RTT - Earnings https://ift.tt/irLnkWI
via IFTTT

Barnes Group Slashes FY22 Outlook As Q2 Revenues Miss Estimates

While reporting financial for the second quarter on Friday, Barnes Group, Inc. (B), a provider of highly engineered products, slashed its adjusted earnings and organic sales growth guidance for the full-year 2022.

from RTT - Earnings https://ift.tt/cfZUdjD
via IFTTT

Standard Chartered Q2 Profit Rises, Updates Income View; Plans $500 Mln Buyback; Stock Up

Shares of Standard Chartered Plc were gaining around 3 percent in the morning trading in London after the British bank reported Friday higher second-quarter results, and updated its forecast for fiscal 2022 income growth. The bank also announced a new $500 million share buyback to start imminently.

from RTT - Earnings https://ift.tt/9vV0QEu
via IFTTT

Alnylam Q2 Loss Widens, SGEN Boosts Revenue Outlook, NVCR To Report LUNAR Study Data In Q1

Seagen Inc. (SGEN) has boosted its full-year 2022 revenue outlook on the back of increased net sales expectations for its drug Adcetris, as well as higher collaboration and license agreement revenues.

from RTT - Earnings https://ift.tt/nIDWw8v
via IFTTT

IAG Posts Narrower Operating Loss Before Exceptional Items In H1; Expects To Be Positive For 2022

International Consolidated Airlines Group (IAG.L, BAIRY.PK, BAY.L) reported that its first-half operating loss before exceptional items narrowed to 467 million euros from a loss of 2.18 billion euros, prior year. Adjusted loss per share in euro cents was 13.8 compared to a loss of 43.7.

from RTT - Earnings https://ift.tt/mKOEp2u
via IFTTT